TY - JOUR
T1 - Corrigendum to How has post-implementation surveillance of high-coverage vaccination with HPV16/18-AS04 vaccine in England added to evidence about its cross-protective effects? Vaccine. 2024 Oct 24;42(24):126215. doi
T2 - 10.1016/j.vaccine.2024.126215. Epub 2024 Aug 29. PMID: 39213982 (Vaccine (2024) 42(24), (S0264410X24008971), (10.1016/j.vaccine.2024.126215))
AU - Navarro-Torné, Adoración
AU - Anderson, Anja
AU - Panwar, Kavita
AU - Ghys, Emmanuelle
AU - Benninghoff, Bernd
AU - Weynants, Vincent
AU - Beddows, Simon
AU - Checchi, Marta
N1 - Publisher Copyright:
© 2024 GlaxoSmithKline Biologicals S.A
PY - 2025/2/15
Y1 - 2025/2/15
N2 - The authors regret the following corrigendum: After the publication of the manuscript, we realised that “dyskariosis” was used for the search in EMBASE instead of the correct spelling “dyskaryosis”. Post-hoc searches in EMBASE both for ‘cervical severe dyskariosis’ and ‘cervical severe dyskaryosis’ search strings resulted in “0” hits retrieved in both cases. Therefore, the final output was not affected by this typo. The authors would like to apologise for any inconvenience caused.
AB - The authors regret the following corrigendum: After the publication of the manuscript, we realised that “dyskariosis” was used for the search in EMBASE instead of the correct spelling “dyskaryosis”. Post-hoc searches in EMBASE both for ‘cervical severe dyskariosis’ and ‘cervical severe dyskaryosis’ search strings resulted in “0” hits retrieved in both cases. Therefore, the final output was not affected by this typo. The authors would like to apologise for any inconvenience caused.
UR - http://www.scopus.com/inward/record.url?scp=85214347017&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2024.126701
DO - 10.1016/j.vaccine.2024.126701
M3 - Comment/debate
AN - SCOPUS:85214347017
SN - 0264-410X
VL - 47
JO - Vaccine
JF - Vaccine
M1 - 126701
ER -
